A detailed history of Bayesian Capital Management, LP transactions in Grifols Sa stock. As of the latest transaction made, Bayesian Capital Management, LP holds 11,891 shares of GRFS stock, worth $102,262. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,891
Holding current value
$102,262
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.28 - $9.38 $74,675 - $111,537
11,891 New
11,891 $105,000
Q3 2023

Nov 14, 2023

BUY
$8.91 - $10.91 $89,991 - $110,191
10,100 New
10,100 $92,000
Q4 2022

Feb 14, 2023

BUY
$5.96 - $8.53 $63,754 - $91,245
10,697 New
10,697 $90,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.84B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.